$MIPI Molecular Insight Pharmaceuticals, Inc. Insider Trading
Get free email notifications about insider trading in Molecular Insight Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Molecular Insight Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Molecular Insight Pharmaceuticals, Inc. for free.
CIK Number: 0001340752
IRS Number: 043412465
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: MIPI
Company Address: 160 SECOND STREET CAMBRIDGE 02142
Prev close: $0.00
Average Daily Volume: 0
Days Low: $0.00
Year Low: $0.00
Year High: $0.00
Molecular Insight Pharmaceuticals, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 28 2011 | MIPI | Molecular Insight ... | Barlow David S | 10% Owner | Sell | S | 0.18 | 21,000 | 3,675 | 2,361,377 | 2.4 M to 2.4 M (-0.88 %) |
Jan 28 2011 | MIPI | Molecular Insight ... | Barlow David S | 10% Owner | Sell | S | 0.17 | 9,000 | 1,539 | 2,382,377 | 2.4 M to 2.4 M (-0.38 %) |
Jan 28 2011 | MIPI | Molecular Insight ... | Barlow David S | 10% Owner | Sell | S | 0.16 | 6,000 | 960 | 2,391,377 | 2.4 M to 2.4 M (-0.25 %) |
Jan 28 2011 | MIPI | Molecular Insight ... | Barlow David S | 10% Owner | Sell | S | 0.14 | 6,000 | 846 | 2,397,377 | 2.4 M to 2.4 M (-0.25 %) |
Jan 28 2011 | MIPI | Molecular Insight ... | Barlow David S | 10% Owner | Sell | S | 0.15 | 17,000 | 2,550 | 2,403,377 | 2.4 M to 2.4 M (-0.70 %) |
Jan 28 2011 | MIPI | Molecular Insight ... | Barlow David S | 10% Owner | Sell | S | 0.18 | 5,000 | 900 | 2,420,377 | 2.4 M to 2.4 M (-0.21 %) |
Jan 28 2011 | MIPI | Molecular Insight ... | Barlow David S | 10% Owner | Sell | S | 0.17 | 33,000 | 5,610 | 2,425,377 | 2.5 M to 2.4 M (-1.34 %) |
Dec 20 2010 | MIPI | Molecular Insight ... | Barlow David S | 10% Owner | Sell | S | 0.20 | 122,000 | 24,400 | 2,458,377 | 2.6 M to 2.5 M (-4.73 %) |
Dec 20 2010 | MIPI | Molecular Insight ... | Barlow David S | 10% Owner | Sell | S | 0.21 | 2,000 | 420 | 2,580,377 | 2.6 M to 2.6 M (-0.08 %) |
Dec 20 2010 | MIPI | Molecular Insight ... | Barlow David S | 10% Owner | Sell | S | 0.19 | 31,000 | 5,890 | 2,582,377 | 2.6 M to 2.6 M (-1.19 %) |
Dec 20 2010 | MIPI | Molecular Insight ... | Barlow David S | 10% Owner | Sell | S | 0.23 | 2,000 | 460 | 2,613,377 | 2.6 M to 2.6 M (-0.08 %) |
Dec 20 2010 | MIPI | Molecular Insight ... | Barlow David S | 10% Owner | Sell | S | 0.22 | 19,000 | 4,180 | 2,615,377 | 2.6 M to 2.6 M (-0.72 %) |
Dec 20 2010 | MIPI | Molecular Insight ... | Barlow David S | 10% Owner | Sell | S | 0.21 | 24,000 | 5,040 | 2,634,377 | 2.7 M to 2.6 M (-0.90 %) |
May 17 2010 | MIPI | Molecular Insight ... | Stylli Harry | Director | Option Exercise | A | 1.85 | 25,000 | 46,250 | 25,000 | |
May 17 2010 | MIPI | Molecular Insight ... | STERLING LIONEL N | Director | Option Exercise | A | 1.85 | 25,000 | 46,250 | 25,000 |
View all Molecular Insight Pharmaceuticals, Inc. insider transactions.